NYSE : IQV
-$4.09 (-1.72%)
4.16%
382
change: -715 | last: 1097178
change: -362 | last: 540143
change: -256 | last: 39941
change: -79 | last: 120731
change: 538 | last: 193-
1000
0.00
change: -99.1002 | last: 0.9911.35B
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-30 | Vanguard Capital Management | 12.71M | 7.49% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2025-08-14 | HARRIS ASSOCIATES L P | 11.75M | 6.80% |
| 2025-05-09 | GIC Private Ltd | 6.54M | 3.71% |
| 2024-08-15 | GIC Private Limited | 9.13M | 5.01% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 20.97M | 10.98% |
| 2022-02-07 | (1) BlackRock, Inc. | 15.14M | 7.90% |
| 2021-01-29 | (1) BlackRock, Inc. | 14.83M | 7.70% |
| 2020-02-10 | The Vanguard Group - 23-1945930 | 19.35M | 9.97% |
| 2020-02-05 | (1) BlackRock, Inc. | 14.69M | 7.60% |
| 2019-03-12 | TPG Biotech Advisors, Inc. | 8.53M | 4.30% |
| 2019-03-12 | David Bonderman | 8.53M | 4.30% |
| 2019-03-12 | TPG Advisors VI, Inc. | 8.53M | 4.30% |
| 2019-03-12 | TPG Group Holdings (SBS) Advisors, Inc. | 8.53M | 4.30% |
| 2019-03-12 | James G. Coulter | 8.53M | 4.30% |
| 2019-03-12 | TPG Advisors V, Inc. | 8.53M | 4.30% |
| 2019-02-14 | Stephen F. Mandel, Jr. | 7.71M | 3.80% |
| 2019-02-14 | Lone Pine Capital LLC | 7.71M | 3.80% |
| 2019-02-08 | (1) BlackRock, Inc. | 10.98M | 5.50% |
| 2018-05-29 | Lone Pine Capital LLC | 10.46M | 5.00% |
| 2018-05-29 | Stephen F. Mandel, Jr. | 10.46M | 5.00% |
| 2016-10-13 | TPG Advisors VI, Inc. | 49.65M | 20.20% |
| 2016-10-13 | TPG Group Holdings (SBS) Advisors, Inc. | 49.65M | 20.20% |
| 2016-10-13 | TPG Biotech Advisors, Inc. | 49.65M | 20.20% |
| 2016-10-13 | David Bonderman | 49.65M | 20.20% |
| 2016-10-13 | TPG Advisors V, Inc. | 49.65M | 20.20% |
| 2016-10-13 | Canada Pension Plan Investment Board | 19.41M | 7.90% |
| 2016-10-13 | CPP Investment Board Private Holdings, Inc. | 17.84M | 7.30% |
| 2016-10-13 | James G. Coulter | 49.65M | 20.20% |
| 2016-02-16 | Temasek Holdings (Private) Limited | 639.17K | 0.50% |
| 2016-02-16 | 13-4064930 | 3.93M | 3.20% |
| 2016-02-16 | Temasek Life Sciences Private Limited | 639.17K | 0.50% |
| 2016-02-16 | Fullerton Management Pte Ltd | 639.17K | 0.50% |
| 2015-02-17 | 0.1% (2) | 148.23K | 0.10% |
| 2015-02-17 | 11.4% (4) | 14.33M | 11.40% |
| 2015-02-17 | 11.4% (3) | 14.33M | 11.40% |
| 2015-02-17 | 1.4% (4) | 1.7M | 1.40% |
| 2015-02-17 | 1.3% (2) | 1.66M | 1.30% |
| 2015-02-17 | 10 | - | 0.00% |
| 2015-02-17 | 0.1% (2) | 163.56K | 0.10% |
| 2015-02-13 | 10 | 6.38M | 5.20% |
| 2015-02-13 | 10 | 6.38M | 5.20% |
| 2015-02-13 | 10 | 6.38M | 5.20% |
| 2015-02-12 | 13-3434400 | 6.73M | 11.00% |
| 2014-02-14 | 2.1% (4) | 2.7M | 2.10% |
| 2014-02-14 | 04-2683227 | 6.74M | 5.23% |
| 2014-02-14 | 0.5% (2) | 713.7K | 0.50% |
| 2014-02-14 | 0.1% (2) | 163.56K | 0.10% |
| 2014-02-14 | 0.1% (2) | 148.23K | 0.10% |
| 2014-02-14 | 16.9% (3) | 22.15M | 16.90% |
| 2014-02-14 | 16.9% (4) | 22.15M | 16.90% |
| 2014-02-14 | 2.0% (2) | 2.66M | 2.00% |
| 2014-02-11 | 10 | 7.89M | 6.12% |
| 2014-02-11 | 10 | 7.89M | 6.12% |
| 2014-02-11 | 10 | 7.89M | 6.12% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $225.41 | 171.9M | $38.75B | $1.98B | $16.17B | $52.94B |
| 2024-12-31 | $196.51 | 181.3M | $35.63B | $1.7B | $14.16B | $48.08B |
| 2023-12-31 | $231.38 | 183.8M | $42.53B | $1.38B | $13.9B | $55.05B |
| 2022-12-31 | $204.89 | 187.6M | $38.44B | $1.22B | $13.01B | $50.23B |
| 2021-12-31 | $282.14 | 191.4M | $54B | $1.37B | $12.44B | $65.07B |
| 2020-12-31 | $179.17 | 191.3M | $34.28B | $1.81B | $12.9B | $45.37B |
| 2019-12-31 | $154.51 | 195.1M | $30.14B | $837M | $12.04B | $41.35B |
| 2018-12-31 | $116.17 | 203.7M | $23.66B | $891M | $11.01B | $33.78B |
| 2017-12-31 | $97.90 | 217.8M | $21.32B | $959M | $10.22B | $30.59B |
| 2016-12-31 | $76.05 | 149.1M | $11.34B | $1.2B | $7.2B | $17.34B |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193.22 | 167.2M | $32.31B | $1.91B | $16.24B | $46.64B |
| 2026-03-31 | $170.54 | 168.4M | $28.72B | $1.95B | $16.06B | $42.84B |
| 2025-12-31 | $225.41 | 170M | $38.32B | $1.98B | $16.17B | $52.51B |
| 2025-09-30 | $189.94 | 170.2M | $32.33B | $1.81B | $15.19B | $45.7B |
| 2025-06-30 | $157.59 | 171.8M | $27.07B | $2.04B | $15.7B | $40.73B |
| 2025-03-31 | $176.30 | 175.7M | $30.98B | $1.74B | $14.51B | $43.74B |
| 2024-12-31 | $196.51 | 178.9M | $35.16B | $1.7B | $14.16B | $47.61B |
| 2024-09-30 | $236.97 | 182.1M | $43.15B | $1.57B | $13.7B | $55.28B |
| 2024-06-30 | $208.49 | 182.2M | $37.99B | $1.54B | $13.45B | $49.89B |
| 2024-03-31 | $248.87 | 181.9M | $45.27B | $1.44B | $13.74B | $57.57B |
| 2023-12-31 | $231.38 | 181.9M | $42.09B | $1.38B | $13.9B | $54.61B |
| 2023-09-30 | $196.75 | 182.9M | $35.99B | $1.22B | $13.85B | $48.61B |